XWELL, Inc. XWEL
- Market cap
- $7.6M
- P/E
- 0.0×
Follow XWEL
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,416.00 | 1,284.00 | 132.00 | 33.00 | 3.00 | 20.60 | 6.20 | 1.39 | 1.26 | 0.43 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| 4,860.00 | 3,120.00 | 2,160.00 | 327.00 | 176.40 | 66.60 | 41.60 | 10.20 | 2.70 | 1.69 |
High Price
|
|||
| 763 | 845 | 703 | 728 | 152 | 429 | 483 | 337 | 312 | 280 |
Employees
|
|||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| 12 | 49 | 50 | 49 | 8 | 74 | 56 | 30 | 34 | 29 |
Revenue
|
|||
| 43.78% | 20.15% | 21.25% | 21.97% | (42.91%) | 43.87% | 21.54% | 12.23% | 26.31% | 25.70% |
Gross Margin
|
|||
| (19) | (16) | (36) | (21) | (92) | 3 | (33) | (28) | (16) | (16) |
EBT
|
|||
| (160.85%) | (32.77%) | (71.68%) | (42.62%) | (1,099.88%) | 4.00% | (58.23%) | (92.98%) | (48.50%) | (55.04%) |
EBT Margin
|
|||
| (24) | (28) | (37) | (21) | (92) | 3 | (33) | (28) | (16) | (16) |
Net Income
|
|||
| 15 | 8 | 28 | 8 | 7 | 5 | 7 | 10 | 2 | 4 |
Depreciation
|
|||
| 951.27 | 2,624.89 | 2,070.00 | 593.82 | 3.76 | 14.14 | 11.95 | 7.21 | 7.35 | 5.25 |
Revenue/Sh
|
|||
| (1,896.19) | (1,548.15) | (1,536.15) | (259.80) | (41.00) | 0.60 | (7.00) | (6.64) | (3.66) | (5.08) |
Earnings/Sh
|
|||
| (669.92) | (654.41) | (271.32) | (1.38) | (11.22) | 2.79 | (5.17) | (3.85) | (2.39) | (1.57) |
Cash Flow/Sh
|
|||
| (5.24) | (245.27) | (118.43) | (27.85) | (1.95) | (1.46) | (1.46) | (0.57) | (0.39) | (0.53) |
Capex/Sh
|
|||
| (675.16) | (899.68) | (389.75) | (29.23) | (13.18) | 1.34 | (6.62) | (4.42) | (2.78) | (2.10) |
Free CF/Sh
|
|||
| 5,092.78 | 2,464.46 | 542.77 | (31.04) | 36.07 | 19.16 | 10.24 | 5.02 | 1.68 | (2.30) |
Book Value/Sh
|
|||
| 0 | 0 | 0 | 0 | 2 | 5 | 5 | 4 | 5 | 6 |
Shares
|
|||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 67.33 | 0.00 | 0.00 | 0.00 | 0.00 |
PE Ratio
|
|||
| 2.76 | 0.66 | 0.09 | 0.07 | 6.33 | 2.86 | 0.65 | 0.23 | 0.21 | 0.09 |
PS Ratio
|
|||
| 0.52 | 0.71 | 0.35 | 0.00 | 0.66 | 2.11 | 0.76 | 0.33 | 0.90 | 0.00 |
PB Ratio
|
|||
| 1.81 | 0.67 | 0.29 | 0.22 | (3.38) | 1.61 | 0.15 | (0.15) | 0.20 | 0.43 |
EV/Sales
|
|||
| (2.55) | (1.94) | (1.55) | (4.38) | 0.96 | 17.07 | (0.27) | 0.25 | (0.52) | (1.08) |
EV/FCF
|
|||
| (8) | (12) | (7) | 0 | (25) | 15 | (24) | (16) | (11) | (9) |
Op' Cash Flow
|
|||
| 0 | (5) | (3) | (2) | (4) | (8) | (7) | (2) | (2) | (3) |
Capex
|
|||
| (9) | (17) | (9) | (2) | (29) | 7 | (31) | (18) | (13) | (12) |
FCF
|
|||
| 19 | 4 | (11) | (12) | 78 | 89 | 36 | 17 | 6 | (7) |
Working Cap'
|
|||
| 7 | 7 | 7 | 9 | 8 | 14 | 14 | — | — | 4 |
Total Debt
|
|||
| (11) | 0 | 3 | 7 | (81) | (92) | (28) | (23) | (12) | 1 |
Net Debt
|
|||
| 64 | 46 | 13 | (3) | 80 | 100 | 48 | 21 | 8 | (13) |
Sh' Equity
|
|||
| (36.03%) | (38.96%) | (77.65%) | (71.57%) | (137.25%) | 2.91% | (33.22%) | (50.71%) | (52.38%) | (154.41%) |
ROA
|
|||
| (20.98%) | (20.01%) | (133.71%) | (210.57%) | 0.00% | 31.10% | (98.05%) | 0.00% | 0.00% | 0.00% |
ROIC
|
|||
| (45.87%) | (52.44%) | (126.21%) | (401.38%) | (232.54%) | 3.71% | (44.41%) | (80.50%) | (117.39%) | 1,115.49% |
ROE
|
|||
XWELL, Inc. peers in Diagnostics & Research
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| NDRA ENDRA Life Sciences Inc. | $8.9M | 0.0× | Compare |
| BIAF bioAffinity Technologies, Inc. | $9.0M | 0.0× | Compare |
| TTOO T2 Biosystems, Inc. | $6.5M | 0.0× | Compare |
| ADVB Advanced Biomed Inc. | $10.4M | 1.3× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| PMD Psychemedics Corporation | $15.7M | 0.0× | Compare |
| DMTKQ DermTech, Inc. | $3.3M | 0.0× | Compare |
| ISPC iSpecimen Inc. | $3.1M | 0.0× | Compare |
| NOTVQ Inotiv, Inc. | $2.8M | 0.0× | Compare |
XWELL, Inc. (XWEL) key facts
- XWELL, Inc. (XWEL) is a Diagnostics & Research company in the Healthcare sector, listed on Nasdaq.
- XWELL, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $29.2 million, down 13.8% from fiscal 2024.
- As of September 25, 2026, XWEL traded at $0.89, a market capitalization of $7.6 million.
- Return on equity was 1,115.5% and debt-to-equity 0.00.
XWELL, Inc. (XWEL) Latest News
7 Jul
XWELL, Inc. enters definitive agreement to divest XpresSpa and XpresTest businesses. Divestiture of core businesses signals major strategic shift affecting future operations and market position.
1 Apr
XWELL, Inc. (XWEL) reported its fiscal 2025 results. Fiscal 2025 results represent major financial disclosure that can significantly alter investor sentiment and company trajectory.
25 Feb
Penny stock XWELL (XWEL) surges over 300% today, sparking debate on rally drivers and whether to chase gains amid volatility. A 300% single-day surge represents a major shift in market dynamics and investor sentiment for XWELL.
24 Feb
XWELL, Inc. (XWEL) announced a private placement expected to raise approximately $31.3 million, priced at the market under Nasdaq rules. Securing $31.3 million in new capital through a private placement enables major strategic initiatives and bolsters financial position.
3 Feb
XWELL, Inc. and PieQ have advanced their AI-powered biosecurity forecasting capabilities following a milestone achievement with the CDC. This collaboration aims to enhance public health responses by leveraging artificial intelligence to predict and manage biosecurity threats more effectively. The partnership with PieQ and the CDC milestone could significantly enhance XWELL's strategic positioning in the biosecurity sector.
8 Jan
XWELL, Inc. has reaffirmed its commitment to biosecurity by appointing a former senior advisor from the CDC to its team. This strategic move aims to enhance the company's focus on health and safety protocols, particularly in response to ongoing public health challenges. The appointment is expected to strengthen XWELL's position in the biosecurity sector and improve its operational capabilities. The appointment of a former CDC advisor is a significant strategic move that could enhance XWELL's market positioning and investor sentiment in the biosecurity space.
18 Dec
XWELL, Inc. has opened a new wellness retail location in Pennsylvania Station, New York City, expanding its services beyond airports. This new site aims to provide health and wellness services to commuters and travelers, enhancing the company's footprint in urban areas. The move aligns with XWELL's strategy to broaden its market presence and cater to a wider audience seeking wellness solutions. The expansion into a high-traffic urban location is expected to moderately enhance XWELL's market presence and financial performance.
14 Nov
XWELL, Inc. (XWEL) reported its third quarter 2025 financial results, highlighting significant revenue growth and improved operational efficiency. The company achieved a notable increase in year-over-year sales, driven by expanded service offerings and strategic partnerships. Management expressed optimism about future growth prospects and outlined plans for further market expansion. The results reflect a strong performance amid a competitive landscape, positioning XWELL favorably for upcoming quarters. The reported revenue growth and strategic plans indicate a significant impact on future performance and market positioning.
5 Nov
XWELL, Inc. has partnered with Ostrichpillow to launch a co-branded eye mask designed to enhance relaxation and sleep quality. This exclusive product combines XWELL's wellness expertise with Ostrichpillow's innovative design, aiming to cater to consumers seeking comfort and improved sleep experiences. The collaboration reflects a strategic move to expand XWELL's product offerings in the wellness market. The collaboration may enhance product innovation and market positioning but is not expected to significantly alter the company's overall trajectory.
30 Oct
XWELL, Inc. has expanded its partnership with Priority Pass to enhance wellness offerings globally. This collaboration aims to provide travelers with access to wellness services, including spa treatments and fitness options, at various airport locations. The initiative is part of XWELL's strategy to integrate health and wellness into travel experiences, catering to the growing demand for wellness-focused services among travelers. The expansion of the partnership with Priority Pass is a significant strategic move that could enhance XWELL's market positioning and financial performance.
XWELL expands Priority Pass partnership to deliver wellness services worldwide. Partnership expansion with Priority Pass broadens XWELL global wellness reach and market access.
12 Sep
XWELL, Inc. has expanded its presence in Florida with the grand opening of the Bloomingdale Wellness Center. This new facility aims to enhance the company's offerings in health and wellness services, aligning with its strategic growth initiatives in the region. The opening of the new wellness center is expected to moderately influence XWELL's market positioning and financial performance.
28 Aug
XWELL, Inc. has expanded its presence in Florida with the grand opening of the Waterford Lakes Wellness Center on September 5. This new facility aims to enhance the company's service offerings in the wellness sector, contributing to its growth strategy in the region. The opening of a new wellness center is expected to moderately influence XWELL's market presence and financial performance.
15 Aug
XWELL, Inc. (XWEL) reported significant developments during its Q2 2025 earnings call, highlighting strategic partnerships aimed at enhancing its market position. The company is focusing on digital evolution to improve operational efficiency and customer engagement. Key initiatives discussed include collaborations with technology firms to innovate service delivery and expand market reach. Financial performance indicators showed promising trends, reflecting the positive impact of these strategies on growth potential. Strategic partnerships and digital initiatives are expected to significantly enhance XWELL's competitive positioning and market performance.
14 Aug
XWELL, Inc. reported its financial results for the second quarter of 2025, highlighting significant growth in revenue and improvements in operational efficiency. The company attributed its success to increased demand for its health and wellness services, alongside strategic partnerships that expanded its market reach. Management expressed optimism about future performance, citing ongoing investments in technology and service enhancements. The results reflect a positive trajectory for XWELL as it navigates a competitive landscape. Significant growth in revenue and operational improvements indicate a strong potential for future performance.
11 Aug
XWELL, Inc. has regained compliance with Nasdaq listing requirements after successfully meeting the minimum bid price of $1 per share for 10 consecutive trading days. This achievement follows a period of non-compliance, which had raised concerns about the company's listing status. The company expressed its commitment to maintaining compliance and enhancing shareholder value moving forward. Regaining Nasdaq compliance positively influences investor sentiment and stability but does not fundamentally alter the company's trajectory.
29 Jul
XWELL, Inc. has launched a new website designed to enhance user experience by providing seamless booking and unified access to a range of health, wellness, and beauty services. The updated platform aims to streamline the customer journey and improve service accessibility. The website launch is expected to moderately influence customer engagement and operational efficiency, impacting overall market performance.
16 Jul
XWELL, Inc. announces the grand opening of its first Florida wellness center in Clearwater on July 25, 2025. The center will offer live facial demonstrations, skin consultations, and complimentary treatments. It aims to provide a spa-like environment for wellness services, including waxing and facials, with plans for additional offerings like massages and IV therapy. A flexible membership model will be introduced, valid at both the Clearwater location and in-airports nationwide, along with a Plaza Discount for local workers. CEO Ezra Ernst emphasizes the importance of blending beauty, wellness, and health in one experience. The opening of a new wellness center and membership model represents a significant strategic move that could enhance XWELL's market presence and customer engagement.
27 Jun
XWELL, Inc. announced that its Xpres Spa brand has been recognized as one of Yelp’s 'Most Loved Airport Brands,' ranking 10th among 25 brands. CEO Ezra Ernst highlighted the growing demand for comfort and quality at airports. The company plans to open new wellness centers in Clearwater, Florida, and New York's Penn Station, expanding its self-care offerings beyond airports. Additionally, XWELL has formed a multi-year partnership with the Orlando Magic as their 'Official Wellness Spa.' The company aims to continue its growth through new locations and strategic partnerships, focusing on equitable wellness access. Expansion into new locations and partnerships indicates significant strategic moves that could enhance market presence and investor sentiment.
17 Jun
XWELL, Inc. has been named the Official Wellness Spa of the Orlando Magic in a new multiyear partnership aimed at expanding its wellness services into local markets in Florida. CEO Ezra Ernst emphasized the opportunity to enhance community wellness and accessibility. The partnership includes brand integration across various platforms, on-court contests, and co-branded events featuring Magic alumni. This collaboration supports XWELL's goals of increasing brand awareness and customer acquisition in Florida, where it aims to grow its medspa presence. The partnership with the Orlando Magic represents a significant strategic move for XWELL, likely enhancing brand visibility and customer engagement in a key growth market.
22 May
XWELL, Inc. has announced an enhanced collaboration with Priority Pass, aimed at expanding its health and wellness services in airport lounges. This partnership will allow XWELL to offer its health services to a broader audience, enhancing the travel experience for Priority Pass members. The collaboration is expected to leverage XWELL's expertise in health and wellness, aligning with the growing demand for such services in travel environments. The collaboration with Priority Pass is a significant strategic move that could enhance XWELL's market presence and service offerings.
XWELL, Inc. has expanded its partnership with Priority Pass, allowing members access to enhanced wellness services at U.S. airport spa locations. The offerings include Zero-Gravity Massage Chairs, HydroMassage, Relaxation Loungers, CERAGEM Therapeutic Massager, and Chakra Bed, aimed at improving travelers' relaxation and wellbeing. This initiative aligns with XWELL's mission to integrate restorative experiences into travel, making it easier for frequent flyers to recharge during their journeys. The partnership with Priority Pass is expected to moderately influence XWELL's market positioning and financial performance by attracting more travelers seeking wellness services.
20 May
XWELL, Inc. reported first quarter 2025 revenue of $7.0 million, down from $8.7 million in Q1 2024, primarily due to lower XpresTest and XpresSpa revenues. The company secured a three-year extension of its genomic surveillance program with the CDC and closed a $4 million private placement. Operating expenses decreased by 11%, while the operating loss increased to $3.2 million. XWELL plans to acquire medical spas in metropolitan areas and expand its wellness offerings, including a new location in New York City's Penn Station. As of March 31, 2025, the company had $3.7 million in cash and no long-term debt. The revenue decline and increased operating loss indicate challenges, but strategic partnerships and expansion plans may balance the impact.
13 Mar
XWELL, Inc. announced plans to acquire select medical spas by the end of 2025, utilizing a recent $4 million private placement to expand into the wellness and beauty sector. The company aims to enhance consumer access to high-quality wellness experiences, focusing on metropolitan areas with strong demand for medspa services. Treatments will include facial aesthetics, injectables, body sculpting, laser therapies, and wellness services. This expansion aligns with XWELL's mission to establish a nationwide presence in beauty and wellness, offering innovative self-care solutions. The acquisition of medical spas represents a significant strategic move that could enhance XWELL's market position and investor sentiment.
15 Jan
XWELL, Inc. has successfully closed a private placement raising $4 million through the issuance of convertible preferred stock and warrants. This financing aims to support the company's growth initiatives and operational strategies. The private placement provides necessary capital that may enhance financial performance and support strategic initiatives.
7 Jan
XWELL, Inc. (XWEL) announces senior leadership appointments and changes. The changes in senior leadership may affect key areas such as financial performance and competitive positioning.
6 Dec
XWELL Inc. is unifying its wellness offerings under a single brand to capitalize on the booming wellness industry, aiming to enhance customer engagement and expand beyond airports with new retail centers. The unification of wellness offerings, integration of AI-driven health solutions, and expansion plans are expected to significantly impact XWELL's future growth and market performance.
5 Dec
XWELL CEO Ezra Ernst outlines company's 2025 objectives to dominate wellness market, unify brands, and drive growth. The article details significant strategic moves and initiatives that are expected to significantly alter XWELL's trajectory and competitive position.
2 Dec
XWELL, Inc. expands out-of-airport spa locations in Florida with six new spas opening in 2025. The expansion of out-of-airport spa locations in Florida is a significant strategic move that can alter the company's trajectory and market performance.
17 Nov
XWELL, Inc. reported a loss of US$0.99 per share in the third quarter of 2024, an improvement from the US$2.38 loss in the same period in 2023. The improved earnings performance may have a moderately noticeable influence on XWELL, Inc.'s financial performance and investor sentiment.